Jefferies Financial Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Jefferies Financial Group’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,000	Closed	-$168K	–	2133
2023 Q1	$168K	Buy	+40,000	New	+$208K	﹤0.01%	1376

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Jefferies Financial Group's CTIC Position: Q2 2023 in Review

Jefferies Financial Group sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 32,680 shares — an estimated $137K sold.

Jefferies Financial Group first reported a position in CTIC in Q1 2023 and held it in 1 quarter. The position peaked at $137K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Jefferies Financial Group reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Jefferies Financial Group sold 32,680 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $137K.
Jefferies Financial Group first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2023 and held it in 1 quarter.
Jefferies Financial Group's CTI BioPharma Corp. (DE) Common Stock position peaked at $137K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Jefferies Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.